Home Tags Medicine
medicine Related Content
An intriguing e-learning programme that helps busy healthcare practitioners stay abreast with changes in diabetes management.
The National Academy of Sciences (PNAS) has published new research which reveals that Huntington's Disease may take affect in people much earlier on in life than originally expected and that a new drug may be paramount in controlling the disease.
A report this week from the Office of Health Economics (OHE) shows the amazing impact medicines have had on the NHS and more widely
Cutting-edge technology synergy in the personalised nanomedicine space: Focus on 3D printing nanomedicines
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechVision synergy Group explains the role of cutting-edge technology in the personalised nanomedicine space, with a special focus on 3D printing nanomedicines.
The Office for National Statistics has today revealed that the number of drug-related deaths in England and Wales is the highest since records began, with opiate-based prescription painkiller Codeine claiming 20% more lives this year compared to last
During the Hybrid Summit 2018 in Bangkok, software providers HEX Innovation launched a blockchain platform enabled service to be used by the medical sectors.
The gap in the long process of progressing a novel scientific insight into a new medicine is often called “the valley of death”. Read below to understand how the strategic alliance between University of Oxford and Novo Nordisk is aiming to combat type 2 diabetes by bridging this gap.
Professor John Wilding from the University of Liverpool charts priorities for improving patient care in the UK when it comes to the prevalent condition, Type 2 diabetes
Cecilia Van Cauwenberghe from Frost & Sullivan shares her expertise on the world of nanomedicines, with a special focus on depicting human health risks hindering clinical translation.
Cecilia Van Cauwenberghe from the TechVision Group at Frost & Sullivan provides a detailed analysis of the present concerns and foreseen opportunities around muscular dystrophy (MD)
Prof Colin J Suckling OBE DSc FRSE, research professor of chemistry at the University of Strathclyde’s Department of Pure & Applied Chemistry shares his views on the challenge of commercialisation when it comes to research into medicinal chemistry
Bradley Moore, CEO of GCAC discusses how artificial intelligence and blockchain (trusted data) solve the paradox of limited medical cannabis data and anecdotal user information
Writer, medical cannabis patient, a grower and budtender for GrassRoots Medicinal in Squamish, Caleb McMillan, provides his thoughts on cannabis developments in North America today
Board Member for Canadians for Fair Access to Medical Marijuana (CFAMM), Peter Thurley, shares his views on medical cannabis advocacy and education issues
CEO of Liva Healthcare, Kristoffer From explains the emergence of personalised e-health care and asks if e-health can close the gap between doctors and diabetic patients
Scientists at the Salk Institute in California have generated the first 3D images of human DNA structure inside living cells
Secretary of State for Health, Jeremy Hunt has announced £20m of extra funding for hospitals to ease pressure on emergency departments ahead of next winter
Angela Morris, CEO, The Wool Packaging Company Ltd talks about challenging pharmaceutical cold chain packaging convention.
Antonino Tramonte, Managing Director, Swiss Institute for Regenerative Medicine outlines how regenerative medicine can help patients.
Dr. Franz E. Weber, University Zurich's Center of Dental Medicine discusses how personalised medicine can be used in bone regeneration.